{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:56:48Z","timestamp":1776448608798,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.therap.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:33:44Z","timestamp":1747247624000},"page":"660-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patients under treatment for sarcoidosis reported adherence issues and would welcome personalized pharmaceutical care: Results from survey online"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8585-5275","authenticated-orcid":false,"given":"Cl\u00e9a","family":"Dubrou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9065-2899","authenticated-orcid":false,"given":"Dorian","family":"Protzenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie S.","family":"Leroyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Cauchois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Kaplanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Hache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2025.05.001_bib0155","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.therap.2025.05.001_bib0160","doi-asserted-by":"crossref","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.therap.2025.05.001_bib0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0037-1604165","article-title":"Neurosarcoidosis","volume":"38","author":"Culver","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.therap.2025.05.001_bib0170","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2025.05.001_bib0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.therap.2025.05.001_bib0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/jcm9020390","article-title":"Comprehensive care for patients with sarcoidosis","volume":"9","author":"Moor","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.therap.2025.05.001_bib0185","doi-asserted-by":"crossref","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.therap.2025.05.001_bib0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.therap.2025.05.001_bib0195","doi-asserted-by":"crossref","first-page":"545413","DOI":"10.3389\/fimmu.2020.545413","article-title":"Treatment of sarcoidosis: a multidisciplinary approach","volume":"11","author":"Gerke","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.therap.2025.05.001_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/17476348.2020.1707672","article-title":"Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis","volume":"14","author":"Pande","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"Suppl. 5","key":"10.1016\/j.therap.2025.05.001_bib0205","first-page":"v1","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.therap.2025.05.001_bib0210","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.therap.2025.05.001_bib0215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1547-5069.2003.tb00001.x","article-title":"Adherence to long-term therapies: evidence for action","volume":"35","author":"Burkhart","year":"2003","journal-title":"J Nurs Scholarsh"},{"key":"10.1016\/j.therap.2025.05.001_bib0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.chest.2020.01.026","article-title":"Association of medication adherence and clinical outcomes in sarcoidosis","volume":"158","author":"Sharp","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.therap.2025.05.001_bib0225","first-page":"1044","article-title":"\u00c9valuation de l\u2019observance du traitement antihypertenseur par un questionnaire\u00a0: mise au point et utilisation dans un service sp\u00e9cialis\u00e9","volume":"30","author":"Girerd","year":"2001","journal-title":"Presse Med"},{"key":"10.1016\/j.therap.2025.05.001_bib0230","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.therap.2025.05.001_bib0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4187\/respcare.03200","article-title":"Asthma and adherence to inhaled corticosteroids: current status and future perspectives","volume":"60","author":"B\u00e5rnes","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.therap.2025.05.001_bib0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MAJ.0000000000000376","article-title":"Assessment of rheumatoid arthritis patients\u2019 adherence to treatment","volume":"349","author":"Gadallah","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.therap.2025.05.001_bib0245","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s12325-009-0069-7","article-title":"Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients","volume":"26","author":"Kane","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.therap.2025.05.001_bib0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1468-1331.2010.03110.x","article-title":"The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis","volume":"18","author":"Devonshire","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.therap.2025.05.001_bib0255","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00004872-200102000-00022","article-title":"Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions","volume":"19","author":"Burnier","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.therap.2025.05.001_bib0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15386\/mpr-1201","article-title":"An overview of the common methods used to measure treatment adherence","volume":"92","author":"Anghel","year":"2019","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.therap.2025.05.001_bib0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jash.2008.12.004","article-title":"Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice","volume":"3","author":"Mulazzi","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.therap.2025.05.001_bib0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.socnet.2019.10.010","article-title":"Re-evaluating standards of human subjects protection for sensitive health data in social media networks","volume":"67","author":"Chu","year":"2021","journal-title":"Soc Networks"},{"key":"10.1016\/j.therap.2025.05.001_bib0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.diabres.2010.08.012","article-title":"The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version","volume":"90","author":"Al-Qazaz","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.therap.2025.05.001_bib0280","first-page":"43","article-title":"Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial","volume":"16","author":"Farsaei","year":"2011","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.therap.2025.05.001_bib0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/ijpp.12598","article-title":"Effect of a pharmacist-led intervention on adherence among patients with a first-time prescription for a cardiovascular medicine: a randomized controlled trial in Norwegian pharmacies","volume":"28","author":"Hovland","year":"2020","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.therap.2025.05.001_bib0290","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12913-021-06217-6","article-title":"Interest in and use of person-centred pharmacy services\u00a0\u2013\u00a0a Swiss study of people with diabetes","volume":"21","author":"Bawab","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.therap.2025.05.001_bib0295","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bcp.12242","article-title":"Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial","volume":"77","author":"Tommelein","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.therap.2025.05.001_bib0300","first-page":"CD012419","article-title":"Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications","volume":"5","author":"Cross","year":"2020","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725000745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725000745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:20:56Z","timestamp":1776446456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595725000745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0040595725000745"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2025.05.001","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients under treatment for sarcoidosis reported adherence issues and would welcome personalized pharmaceutical care: Results from survey online","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}